Tenet Healthcare Corporation $THC Shares Bought by Wedge Capital Management L L P NC

Wedge Capital Management L L P NC lifted its stake in shares of Tenet Healthcare Corporation (NYSE:THC) by 37.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 221,453 shares of the company’s stock after buying an additional 60,478 shares during the quarter. Wedge Capital Management L L P NC’s holdings in Tenet Healthcare were worth $41,429,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. NewEdge Advisors LLC increased its position in shares of Tenet Healthcare by 6.1% during the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock worth $389,000 after purchasing an additional 166 shares in the last quarter. Jones Financial Companies Lllp boosted its holdings in shares of Tenet Healthcare by 299.1% in the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after acquiring an additional 1,274 shares during the period. Sivia Capital Partners LLC acquired a new position in shares of Tenet Healthcare in the 2nd quarter valued at $290,000. Quantbot Technologies LP acquired a new stake in Tenet Healthcare during the 2nd quarter worth $65,000. Finally, Amundi increased its stake in Tenet Healthcare by 4,207.8% in the second quarter. Amundi now owns 27,010 shares of the company’s stock valued at $4,652,000 after purchasing an additional 26,383 shares during the period. 95.44% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Tenet Healthcare

In related news, Director Roy Blunt sold 600 shares of the business’s stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $262.68, for a total transaction of $157,608.00. Following the sale, the director owned 4,589 shares of the company’s stock, valued at approximately $1,205,438.52. The trade was a 11.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Tammy Romo sold 2,500 shares of the company’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $260.83, for a total transaction of $652,075.00. Following the transaction, the director owned 28,284 shares in the company, valued at $7,377,315.72. The trade was a 8.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 41,375 shares of company stock valued at $9,793,347. 0.97% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on THC shares. UBS Group raised their price target on Tenet Healthcare from $288.00 to $308.00 and gave the stock a “buy” rating in a report on Monday, July 27th. Barclays increased their price objective on Tenet Healthcare from $240.00 to $271.00 and gave the stock an “overweight” rating in a research report on Friday, July 24th. Mizuho set a $290.00 target price on Tenet Healthcare in a report on Monday. The Goldman Sachs Group reaffirmed a “buy” rating and set a $305.00 price target on shares of Tenet Healthcare in a report on Tuesday, July 28th. Finally, Piper Sandler set a $308.00 price objective on shares of Tenet Healthcare in a research note on Monday, July 27th. Seventeen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $272.25.

Tenet Healthcare Stock Performance

Shares of THC stock opened at $259.74 on Wednesday. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00. The stock has a 50 day simple moving average of $203.92 and a 200-day simple moving average of $202.38. The company has a market cap of $20.91 billion, a price-to-earnings ratio of 10.02, a price-to-earnings-growth ratio of 0.99 and a beta of 1.23. Tenet Healthcare Corporation has a 12-month low of $157.58 and a 12-month high of $265.32.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The firm had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. During the same period in the previous year, the business earned $4.02 earnings per share. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, equities analysts forecast that Tenet Healthcare Corporation will post 21.09 EPS for the current year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.